Breakthrough: Two New Drug Candidates Successfully Repair Nerve Damage in MS Research
Photo: Towfiqu barbhuiya / Unsplash
Researchers at the University of Helsinki have identified two drug molecules that successfully trigger myelin regrowth in multiple sclerosis models—a significant achievement, as previous remyelination drug candidates have failed to show results. This discovery offers new hope for MS patients, as myelin repair could help restore nerve function and slow disease progression.
Researchers at the University of Helsinki have identified two drug molecules that successfully trigger myelin regrowth in multiple sclerosis models—a significant achievement, as previous remyelination drug candidates have failed to show results. This discovery offers new hope for MS patients, as myelin repair could help restore nerve function and slow disease progression.